Skip to main content
Top

Current Oncology Reports

Issue 3/2012

Content (6 Articles)

Genitourinary Cancers (E Jonasch, Section Editor)

Circulating Biomarkers in Advanced Renal Cell Carcinoma: Clinical Applications

Maria Hernandez-Yanez, John V. Heymach, Amado J. Zurita

Genitourinary Cancers (E Jonasch, Section Editor)

Immunological Heterogeneity of the RCC Microenvironment: Do Targeted Therapies Influence Immune Response?

Axel Bex, Tamara Etto, Florry Vyth-Dreese, Christian Blank, Arjan W. Griffioen

Genitourinary Cancers (E Jonasch, Section Editor)

Renal Cell Carcinoma Deep Sequencing: Recent Developments

Leslie J. Farber, Kyle Furge, Bin Tean Teh

Gastrointestinal Cancers (L Saltz, Section Editor)

Pancreatic Neuroendocrine and Carcinoid Tumors: What’s New, What’s Old, and What’s Different?

Diane Reidy-Lagunes, Raymond Thornton

Gastrointestinal Cancers (L Saltz, Section Editor)

Management of Hepatocellular Carcinoma: Beyond Sorafenib

Stephen L. Chan, Tony Mok, Brigette B. Y. Ma

Gastrointestinal Cancers (L Saltz, Section Editor)

Toward the Non-surgical Management of Locally Advanced Rectal Cancer

Alice Dewdney, David Cunningham

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine